Name Funds holding
in top 10
Growth Growth % Return since
31 Mar ‘22
201
4 +1 +33% 44.8%
202
4 +1 +33% 23.5%
203
4 +1 +33% 133%
BMY icon
204
Bristol-Myers Squibb
BMY
$104B
85 +21 +33% 30.2%
205
37 +9 +32% 5.78%
206
33 +8 +32% 117%
207
29 +7 +32% 28.7%
208
21 +5 +31% 40.2%
209
34 +8 +31% 39.4%
210
17 +4 +31% 74.4%
DXCM icon
211
DexCom
DXCM
$25.3B
17 +4 +31% 49.3%
212
47 +11 +31% 49.3%
213
26 +6 +30% 29.5%
214
13 +3 +30% 127%
215
66 +15 +29% 32.7%
216
44 +10 +29% 36.3%
217
27 +6 +29% 15.5%
218
18 +4 +29% 15.5%
219
9 +2 +29% 441%
220
37 +8 +28% 40.5%
221
70 +15 +27% 34%
222
28 +6 +27% 37.9%
223
14 +3 +27% 7.24%
224
95 +20 +27% 20.2%
225
19 +4 +27% 37.6%